A mouse model of chronic Pseudomonas-induced bronchopulmonary inflammation that mimics chronic cystic fibrosis (CF) lung disease was employed to determine whether this inflammatory milieu influences immune responses to adenoviral vectors. Pseudomonas-infected and control mice were inoculated intranasally with a second-generation type 2 adenovirus (Ad2) vector (Ad2/bgal-2). After 3 weeks, serum and airway Ad2-specific antibodies and Ad2 vector-directed, cytotoxic T-lymphocyte (CTL) activity in splenocytes were measured. No differences in humoral immunity were observed between Pseudomonas-infected mice and controls. However, there was a two-to three-fold increase in Adspecific CTL activity in the Pseudomonas-infected mice compared to control mice. MHC class I-dependent antigen presentation by antigen-presenting cells (APC) from lungs of Pseudomonas-infected mice was also significantly increased compared to APC from control mice, suggesting a mechanism that may contribute to increased Ad-specific CD8 þ CTL responses. It was concluded that Ad-specific CTL activity is enhanced in the setting of pre-existing chronic Pseudomonas-induced lung inflammation similar to CF lung disease, and that increased antigen presentation via MHC class I in this setting may be one underlying mechanism. These findings underscore the importance of considering the influence of the disease milieu when evaluating modes of gene therapy for such diseases in animal models.
Introduction
A hallmark of the lung disease in patients with cystic fibrosis (CF) is the development of an intense chronic inflammation of the airways, usually associated with Pseudomonas endobronchial infection. 1 The early pathogenesis of this chronic inflammatory process and its relationship to the fundamental defect in CFTR have yet to be defined. However, this chronic pathologic process ultimately accounts for most of the morbidity and mortality in CF patients. 2 A number of approaches to the genetic correction of the underlying defect in airway epithelial cells of CF patients, including recombinant adenovirus (Ad) vectors, have been developed and are being refined. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The general premise underlying the current study is that in order to optimize the development of gene therapy in CF patients, it is essential to understand the effects of the chronic inflammatory milieu of the CF airway on the delivery and expression of transgenes by proposed gene therapy vehicles directed to that site. Specific immune responses to Ad vectors clearly impair transgene delivery and duration of expression on subsequent administration. 13, 14 Based on the published data, the specific immune mechanisms most important in interfering with transgene expression by these vectors in the airways are the systemic and local neutralizing antibody responses, which appear to inhibit gene transfer on subsequent administrations, and the MHC class I-restricted CD8 þ cytotoxic T-cell responses that may specifically eliminate transfected epithelial cells. 15, 16 In previous studies, we reported that chronic Pseudomonas-induced lung inflammation in mice reduced the extent of Ad-mediated gene transfer in the airways. 17 As the milieu of the chronically infected lung in CF patients contains a number of cytokines and other mediators that may influence inflammatory and immune responses, 18 we proposed that specific immune responses already known to interfere with Ad-mediated transgene delivery and expression, even in the absence of pre-existing inflammation, may be exaggerated in a setting of chronic Pseudomonas-induced airway inflammation in mice, similar to that found in the airways of CF patients.
Results

Cytokine concentrations in bronchoalveolar lavage fluid (BAL) and lung histopathology
To confirm important similarities in the inflammatory milieu of the lungs between the mouse model employed in the current studies and CF lung disease, representative lungs from mice that had received Pseudomonas-laden or sterile agarose beads were examined for concentrations of IL-1, TNFa, and IL-6 in BAL 3 days after bead inoculation. As shown in Figure 1 , concentrations of all three cytokines, corrected by the urea method for epithelial lining fluid (ELF) volumes, were markedly higher in mice that received Pseudomonas-laden beads than in mice that received sterile bead controls; only IL-1b was even detectable in the latter group and these were basal levels similar to untreated controls (not shown). Each of these three cytokines is also present at very high concentrations in BAL of patients with CF and chronic Pseudomonas lung infection. 18 In addition, as in our previously published studies, 17 histopathologic examination of the lungs of representative groups of mice 7 days after inoculation with Pseudomonas-laden or sterile beads confirmed a fivefold or greater increase in areal lung inflammation for mice that received the Pseudomonas-laden beads compared to sterile bead controls (not shown), with inflammatory cell infiltrates similar to those observed in lung sections from patients with CF. Thus, the inflammatory features of the mouse model employed in the current studies are similar to those of CF lung disease.
Specific cellular immune responses to adenoviral vectors
Cytotoxic T-lymphocyte (CTL) responses against Ad vectors are known in many models to reduce the duration of transgene expression associated with Ad vectors due to specific destruction of transduced cells. To determine whether pre-existing chronic airway inflammation similar to that in CF would enhance CTL responses to Ad vectors, we examined the effects of the airway milieu associated with chronic Pseudomonas infection in mice on the magnitude of the CTL response to second-generation Ad vectors administered in that setting. In preliminary experiments (not shown), splenocytes pooled from five C57BL/6 mice inoculated with Pseudomonas-containing agarose beads followed by the recombinant replication-deficient type 2 adenovirus (Ad2)/bgal-2 vector, according to the protocol described, exhibited markedly elevated CTL responses to Ad2/bgal-2-infected targets compared to the pooled splenocytes of five control mice that received sterile beads instead of Pseudomonas-laden beads. To permit statistically valid confirmation of this preliminary finding, similar experiments were performed with splenocytes from individual mice. After in vitro stimulation, cytolytic activity against 51 Cr-labeled syngeneic fibroblasts infected with either the same Ad2/bgal-2 vector or an Ad2 'empty vector' was measured over a range of effector:target ratios. As shown in Figure 2a , the level of CTL activity against Ad2/bgal-2-infected targets in Pseudomonas-infected mice (n ¼ 7) was nearly twice that observed in mice that received sterile beads (n ¼ 9; Po0.005 by t-test). Similarly, as shown in Figure 2b , the CTL response against targets infected with the Ad2 'empty vector' (no transgene) was also enhanced more than two-fold in splenocytes from mice treated with Pseudomonas beads compared to sterile beads (Po0.003 for all but the lowest E:T ratio tested). These results indicate that Ad-specific CTL responses, which are known to reduce the duration of transgene expression, are enhanced significantly when the vector is administered initially in the setting of chronic Pseudomonas bronchopulmonary infection similar to that in CF. It was also apparent, as has been shown previously 15 and as suggested by the higher overall values in Figure 2a versus b, that part of the response to the Ad2/bgal2-infected targets was directed against the transgene product.
Specific humoral responses to adenoviral vectors
Development of specific antibodies to Ad vectors has been shown to reduce the delivery of transgenes due to neutralization of the vector. 16 . We sought to determine if administration of an Ad vector in the setting of chronic Pseudomonas airway infection/inflammation in the agarose bead model led to enhanced production of Adspecific antibodies against the vector. Figure 3 shows results for Ad2-specific antibodies by ELISA for samples of the serum (Figure 3a) and BAL (Figure 3b ) of mice that received the Ad2/bgal-2 vector 7 days after inoculation with either Pseudomonas-containing or sterile agarose beads. Although ELISA values for the Pseudomonasinfected mice were somewhat higher than the control groups for both the serum and BAL, the differences were not statistically significant. Similarly, when the same sera were tested for Ad2-specific neutralizing antibodies (Figure 4 ), no significant differences were seen among the groups for the serum (Figure 4a ) or BAL ( Figure 4b ). Thus, humoral immunity to the Ad vector appears not to be affected in the same way that CTL activity is affected by the pre-existing chronic Pseudomonas lung infection.
MHC class I-dependent antigen presentation by antigen-presenting cells (APC) from Pseudomonasinfected mice versus controls
The mechanisms by which chronic Pseudomonas lung infection promotes the enhanced Ad-specific CD8 þ CTL responses described above have not been determined. As Figure 1 Cytokine concentrations in BAL, corrected for volumes of ELF, from mice infected in the Pseudomonas agarose bead model. Concentrations of IL-1, TNFa, and IL-6 were measured in BAL of mice 3 days after inoculation with Pseudomonas-laden beads (n ¼ 5) versus sterile beads (n ¼ 6). Results were corrected by the urea method to yield pg/ml in ELF, as shown. All three cytokines were present at markedly higher concentrations in the ELF of Pseudomonas-infected mice versus mice that received sterile beads.
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MHC class I-dependent antigen presentation is a critical antecedent to the development of specific CD8 þ CTL responses, we examined whether APC from lungs of Pseudomonas-infected mice could present a peptide antigen more effectively to CD8 þ T cells than APC from the control mice. As determined in a bioassay for IL-2 release ( Figure 5 ), the CD8 þ T-hybridoma response to a specific ovalbumin (OVA) peptide presented on APC from BAL of Pseudomonas-infected mice was between two-and three-fold greater than for APC from mice that received sterile beads or saline controls, for each density of APC tested (Po0.05). These data are consistent with the possibility that enhanced MHC class I-dependent antigen presentation is a mechanism that contributes to the observed enhancement of Ad-specific CD8 þ CTL responses in mice chronically infected with Pseudomonas.
Discussion
In the study of recombinant adenoviral vectors as potential agents for gene therapy, it has become clear that specific immune responses by the host against the vector have adverse impacts on subsequent Admediated gene delivery and on transgene expression. The humoral response, specifically neutralizing antibodies against the vector, interferes with subsequent for mice that had received Pseudomonas-laden agarose beads prior to inoculation with Ad2/bgal-2 as described (n ¼ 7). Controls shown include mice that received sterile agarose beads in place of Pseudomonas-laden beads (n ¼ 9), and mice that received either Pseudomonas-laden or sterile beads, but no Ad vector (background controls; n ¼ 3 for each). (b) Shows similar data for the same groups of mice, except that the target cells were infected with the Ad2 'empty vector' to eliminate activity directed against the transgene product. For most E:T ratios in both (a) and (b), the target lysis was significantly greater (*Po0.005) for equivalent numbers of splenocytes from mice that received Pseudomonas-infected agarose beads versus sterile beads before inoculation with the Ad2/bgal-2 vector. Background lysis of uninfected fibroblasts (not shown) was uniformly o3%.
Figure 3
Antibody levels against Ad2 in the serum and BAL as measured by ELISA. The serum (a) and BAL fluid (b) from mice that received the Ad2/bgal-2 vector after being inoculated with Pseudomonas-laden or sterile agarose beads or controls without beads were assayed for specific antibodies to Ad2, using UV-inactivated wild-type Ad2 as the test antigen, as described. Sera were tested at dilutions of 1:100, 1:300, and 1:1000. Although values for the mice that had received Pseudomonas beads were consistently higher, overall, than for the control groups, the differences were not statistically significant. BAL fluid was assayed only at a dilution of 1:3, and, although values for Pseudomonas-infected mice were somewhat higher than for the control groups, the differences were not statistically significant.
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delivery by the vector to target epithelial cells. 16 In addition, in several systems, the Ad-specific CD8 þ cytotoxic T-cell response shortens the duration of transgene expression by targeting transduced cells for destruction. 15, 16, 19 These immune responses are of sufficient importance, even in previously healthy lungs, that a number of strategies to limit these specific responses have been explored [20] [21] [22] [23] [24] in attempts to improve Admediated gene transfer and/or transgene expression.
Chronic infection and inflammation in the CF lung has been associated with abnormal and exaggerated local and systemic humoral responses to Pseudomonas antigens, [25] [26] [27] although these responses do not assist the CF host in clearance of this chronic infection. It has been proposed that high concentrations of IL-6 in this environment, a cytokine known to stimulate B-cell differentiation and antibody production, may be partly responsible for this exaggerated response, 18 but this remains speculative. Whether and to what extent the specific immune responses to Ad vectors administered to the lungs might be influenced by this pre-existing inflammatory environment has not been determined previously. Our current findings indicate that Ad-specific CTL responses are markedly enhanced in this setting, although antibody responses appear not to be changed significantly. Thus, the environment of chronic Pseudomonas infection in the airways not only reduces shortterm transgene expression, as we have published previously, 17 but also may interfere indirectly with the duration of transgene expression by increasing the extent to which transduced epithelial cells are destroyed by specific CTL responses.
Cytokine production and antigen presentation are inter-related factors that may influence specific immune responses, especially as certain cytokines, including TNFa can alter the immunomodulatory phenotype of macrophages, promoting the development of an immunostimulatory phenotype. 28 Moreover, TNFa, IL-1, and IL-6, which are prominent cytokines in the chronically infected CF lung 18 and were present at high levels early in the course of chronic Pseudomonas infection in the current murine model, have been identified as costimulatory factors that may enhance both MHC class I-and class II-dependent antigen presentation by macrophages. 29 The mechanisms that account for the observed increase in CTL responses in chronic Pseudomonas infection have not been fully elucidated. However, MHC class I-dependent antigen presentation is a critical antecedent to the development of specific CD8 þ CTL responses, and our findings that both processes are increased in this setting are consistent with the possibility that enhanced antigen presentation is one mechan- Figure 4 Antibody levels against Ad2 in the serum and BAL as measured by neutralization. The Ad2/bgal-2 vector was incubated as described with the serum or BAL (same samples as for Figure 3 ) at the dilutions indicated before being added to cultured 293 cells. The reduction in b-gal activity in lysates of cells harvested after 24 h compared to results with untreated vector was used to determine the percent neutralization for the serum (a) or BAL (b) dilution indicated. No significant differences were observed between Pseudomonas-infected mice and controls for either the serum or BAL neutralizing antibodies against the vector. Figure 5 MHC class-I-dependent antigen presentation by APC from lungs of chronically infected mice and controls. BAL fluid cells from mice inoculated with Pseudomonas beads, sterile beads, or saline were incubated with OVA (257-264) peptide. These cells were then used to stimulate CD8OVA T-hybridoma cells. The effectiveness of antigen presentation was measured by the extent of IL-2 release, determined in a CTLL-2 cell bioassay using an Alamar Blue redox reaction. As shown, the effectiveness of antigen presentation by APC from the Pseudomonas-infected mice was significantly greater (n ¼ 3; Po0.05) for each dilution of APCs shown compared to the results for control mice that received either sterile beads or saline.
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MF Tosi et al ism contributing to the observed increase in specific CTL activity. It is presumed that the enhanced antigen presentation observed was the result of increased expression of class I MHC on the APC, although alternative explanations cannot be ruled out. It is worth noting that our previously published data demonstrated a marked reduction (X60%) in short-term Ad-mediated transgene expression for mice infected in the chronic Pseudomonas agarose bead model. 17 As this implies a concomitant reduction in synthesis of viral and transgene antigens available to stimulate the afferent limb of the immune response, it is possible that, in the chronically inflamed lung, these afferent mechanisms may be stimulated to an even greater relative degree than the currently observed enhancement of the relevant effector response (CTL activity) would suggest. It is also important to recognize that relatively long-term expression of a nonimmunogenic transgene has been observed in several models despite the presence of Ad-specific CTLs, suggesting that, in some cases, CTLs specific for the transgene product may be at least as important as those directed against the vector itself. 30, 31 Whether this particular observation also would hold in the setting of pre-existing lung inflammation has not been examined.
The inflammation in the mouse model employed may not be fully reflective of what occurs in the CF lung. However, many important features of this model do mimic events in the CF lung very closely, including the cellular responses, cytokine profile, and histopathology, and there is not, currently, an animal model that is better suited to addressing the questions of the current study. Previous studies with CF mice (homozygous for the S489X mutation of CFTR) have demonstrated an enhanced inflammatory response to Pseudomonas infection compared to wild-type littermates in the agarose bead model, 32 suggesting that CF mice might exhibit an even more pronounced enhancement of CTL responses than the wild-type mice in our current study. Although it would be intriguing to test this possibility, the markedly reduced survival of CF versus wild-type mice in the above-cited studies would impose significant limitations on such an approach.
Whether adenoviral vectors ultimately will serve as vehicles for clinically effective gene therapy in CF remains to be determined. Previous data from our laboratory, 17 taken together with the current studies, suggest that the Pseudomonas-induced chronic inflammatory airway milieu in CF may provide both its own direct physical or biochemical impediments to Ad-mediated gene transfer and may additionally intensify some of the immunologic responses that, even in the absence of pre-existing lung inflammation, have been associated with reduced duration of Ad-mediated transgene expression. Our findings emphasize the importance of considering the influence of the existing state of inflammation in the CF airway, when testing gene delivery systems in animal models with a view toward treatment of patients with this disease.
Methods
Laboratory reagents
Except where otherwise indicated all laboratory reagents, buffers, media, and antibodies were purchased from Sigma Chemical Company (St Louis, MO, USA) or GIBCO (Grand Is., NY, USA).
Bacteria
A mucoid strain of Pseudomonas aeruginosa (M57-15) isolated from a patient with CF at CWRU was employed for all studies reported. These bacteria were used in the agarose bead model of chronic Pseudomonas bronchopulmonary infection described below. 17 The mucoid phenotype of these organisms was confirmed before each experiment by plating on tryptic soy agar.
Viruses and vectors
Ad2 vectors used in these studies were modified by the deletion of the entire E1 region and all of the E4 region with the exception of open-reading frame 6. 15 All inoculations of mice employed a vector as described above, in which an expression cassette containing the b-gal gene driven by the CMV promoter was inserted in place of the E1 region (Ad2/bgal-2). For studies of cytotoxic T-cell activity detailed below, target cells were infected with the bgal-containing vector described above or, alternatively, with an identical vector without a transgene ('empty vector'). A UV-inactivated wild-type Ad2 strain was employed as a source of antigen in ELISA assays. For titration of neutralizing antibodies, the bgalcontaining vector was employed. Purified stocks of vectors at densities of E5 Â 10 10 -2 Â 10 11 i.u./ml were stored at À801.
Mice
Male C57BL/6 mice were purchased from Charles River Laboratories (Wilmington, MA, USA) at 6-8 weeks of age. After arrival, mice were allowed to stabilize in the new environment for 1 week before being used in experiments. These specific pathogen-free mice were maintained in microisolator units and fed autoclaved rodent chow and water ad libitum.
Agarose bead model of chronic Pseudomonas bronchopulmonary infection
With minor modifications as described previously, 17 we adapted an agarose bead chronic lung infection model in mice similar to that reported by Starke et al, 33 after the model initially described by Cash et al in rats. 34 The animal research protocol was reviewed and approved by the Case Western Reserve University Institutional Animal Care and Use Committee. In brief, the mucoid M57-15 isolate of P. aeruginosa was cultured in tryptic soy broth to late log phase, and a slurry of Pseudomonasimpregnated agarose beads was prepared as described previously. 17, 33, 34 Sterile beads prepared with broth in the absence of bacteria served as a control. A measure of 50 ml of a 1:10 dilution of the agarose bead slurry, containing approximately 5 Â 10 4 CFU, was instilled transtracheally via a 22-gauge soft catheter into the right mainstem bronchus of an anesthetized mouse after making a small ventral neck incision, which would heal in about 3 days.
For studies of cytokine concentration in BAL fluid 3 days after agarose bead instillation, mice were euthanasized by CO2 overdose and intracardiac exsanguination, and the trachea was canulated in situ with a 22-gauge bead-tipped needle. Lungs were then lavaged three times with 1.0 ml of sterile PBS, and a total of at least 2.5 ml of lavage fluid was recovered by gentle aspiration. After removal of cells by centrifugation, supernatants Antiadenoviral CTL in chronic lung inflammation MF Tosi et al were treated with phenylmethylsufonyl fluoride (100 mM) and EDTA (5 mM) and stored in polypropylene tubes at À801 until assayed. Some mice were killed at 7-10 days to confirm the expected histopathology of the chronic Pseudomonas infection. The lungs were removed and inflation fixed with 2% paraformaldehyde in PBS. After embedding in paraffin, sections were prepared and stained with hematoxylin/eosin using standard histologic techniques.
Measurement of cytokines in BAL fluid
Kits from R&D Systems (Minneapolis, MN, USA) were used according to the manufacturer's instructions to measure cytokine concentrations in BAL fluid supernatants of mice by sandwich ELISA. Values for each cytokine were determined by comparison with a standard curve generated using a defined standard at specified serial dilutions. The limits of detection for the cytokines assayed was 5.0 pg/ml. The BAL fluid was assayed in duplicate and values were corrected for the volume of respiratory ELF recovered by urea dilution compared to the serum urea concentrations. 18 Protocol for inoculation with vectors and collection of samples for analysis On day 6 after inoculation with agarose beads, mice were inoculated intranasally under light ether anesthesia with the Ad2/bgal-2 vector described above (E10 9 infectious units in 50 ml) or saline as a control. For the experiments reported, 21 days after inoculation with the Ad2 vector, mice were killed by CO 2 overdose followed by intracardiac puncture and exsanguination. Blood was centrifuged and serum stored, frozen at À801. As described above, the lungs were lavaged in situ via the exposed trachea with three cycles of instillation and aspiration of 1.0 ml PBS, and BAL and fluid was centrifuged and supernatants frozen at À801 for later analysis. The spleens were removed, and the cells dispersed into the culture medium by rotary compression between sterile ground glass surfaces.
Cytotoxic T-cell assay
Spleen cells from mice were stimulated with mitomycin C-inactivated SVB6KHA fibroblasts (gift from Linda Gooding, Emory University) infected with Ad2/bgal-2 to expand vector-specific CTLs. After 6 days of incubation, cytolytic activity was tested at various effector:target ratios against 51 Cr-labeled syngeneic target fibroblasts that were either uninfected or infected with Ad2/ bgal-2 or Ad2/empty vector. The fibroblasts were treated with recombinant mouse g-interferon (Genzyme) to enhance MHC class I expression. After 5 h of incubation, cell-free supernatant was collected from each well and counted in a MicroBeta Trilux liquid scintillation counter (Wallac Inc., Gaithersburg, MD, USA). The amount of 51 Cr spontaneously released was obtained by incubating target fibroblasts in the medium alone and the total amount of 51 Cr incorporated was determined by adding 1% Triton X-100 in distilled water. The percentage lysis was calculated as follows:
% lysis ¼ ðsample cpmÞ À ðspontaneous cpmÞ ðtotal cpmÞ À ðspontaneous cpmÞ Â100:
15 Ad2-specific antibodies in the serum and BAL fluid by ELISA An ELISA assay was used to measure Ad2-specific antibodies in the sera and BAL from the mice. Purified psoralen-UV-inactivated inactivated wild-type Ad2 at 50 ng protein/well in carbonate buffer, pH 8, was bound to the microtiter wells overnight in the cold (control wells received diluent alone). Wells were blocked with 5% BSA for 2 h at 251C, then washed 3 Â . Mouse serum at dilutions of 1:100, 1:300, and 1:1000 was added for 1 h, then wells were washed 3 Â . An alkaline phosphatase-tagged goat anti-mouse Ig (binds IgG, A, M) was added for 1 h, then washed 3 Â , and the substrate p-nitrophenyl phosphate (1 mg/ml) was added. OD readings at 405 nm were made at 30-min intervals. Identical assays were carried out on BAL from the same mice, but at a single dilution of 1:3.
Neutralizing antibodies to the vector in the serum +and BAL
For measurement of neutralizing antibodies in the serum, serial semi-log 10 dilutions of each sample (100 ml) were mixed with the Ad2/bgal2 vector (10 6 i.u. in 20 ml) for 1 h at 371C. This mixture was then overlaid on monolayers of 293 cells near confluence in microtiter wells. After 60 min, 100 ml of the culture medium was added to each well, and the following day cells were lysed and the lysates assayed for b-gal activity using the Galactolight Plus s kit (TROPIX, Worcester, MA, USA). The percent neutralization of reporter gene expression was calculated and plotted against the serum dilution factor. The 293 cell line usually exhibits nearly 100% transduction by Ad2 under these conditions in the absence of neutralizing antibodies. 16 Measurement of neutralizing antibodies in BAL fluid was performed in a similar manner, except that the extent of neutralization was compared only at 1:2 and 1:6 dilutions of BAL fluid.
MHC class I-dependent antigen presentation to CD8 þ T Cells
Mice inoculated with Pseudomonas-laden agarose beads, sterile beads, or saline controls were killed on day 6, the day that mice were ordinarily inoculated with the Ad vector for subsequent studies of immune responses described above, and their lungs were lavaged three times with 1.0 ml saline. The total BAL fluid from each mouse was centrifuged, and the cells were resuspended in 1.0 ml for counting. Cells were pooled from two to three mice to assure sufficient cell numbers from each condition, and were placed in microtiter wells at densities of from 300 to 5000 cells/well (cell preparations contained between 60 and 75% macrophages). Adapting a method described previously, 35 synthetic peptide derived from OVA (257-264), was added to each well, to permit binding of the peptide to MHC class I (K b ) molecules on the cells. After washing away free peptide, an equal number of CD8OVA T-hybridoma cells, specific for OVA (257-264)-K b complexes, was added to each well and allowed to incubate overnight. The response by the T-hybridoma cells to stimulation by the peptide-MHC complex is measured by IL-2 release, determined in a bioassay for the stimulation of the IL-2-dependent cell line, CTLL-2. The final readout was an Alamar Blue redox reaction, quantitated by the increase in the Antiadenoviral CTL in chronic lung inflammation MF Tosi et al difference between absorbance at 550 and 595 nm, which parallels CTLL-2 cell proliferation. 36 
Statistical analysis
Initial statistical comparisons were made using ANOVA, followed by secondary comparisons made with the Student's t-test. It was required that Po0.05 in order for differences between groups to achieve statistical significance.
